|
|
|
|
|
by micromacrofoot
1691 days ago
|
|
The abstract from your linked paper seems to indicate the risk is minimal. >According to the US Centers for Disease Control and Prevention, myocarditis/pericarditis rates are ≈12.6 cases per million doses of second-dose mRNA vaccine among individuals 12 to 39 years of age That's a 0.0013% chance of getting something that "almost all" patients had resolution of with or without treatment: >Almost all patients had resolution of symptoms and signs and improvement in diagnostic markers and imaging with or without treatment. Despite rare cases of myocarditis, the benefit-risk assessment for COVID-19 vaccination shows a favorable balance for all age and sex groups; therefore, COVID-19 vaccination is recommended for everyone ≥12 years of age. |
|